Serum Proteomics from a Phase III, Randomized, Placebo-Controlled Study of Patients with Active Lupus Nephritis: Correlation with Baseline Disease Characteristics and Response to Therapy-MedSci.cn

Serum Proteomics from a Phase III, Randomized, Placebo-Controlled Study of Patients with Active Lupus Nephritis: Correlation with Baseline Disease Characteristics and Response to Therapy

Wang, SL; Furie, R; Dooley, MA; Wofsy, D; Takeuchi, T; Malvar, A; Doria, A; Romero-Diaz, J; Chan, TM; Appel, G; Jayne, D; Hu, S; Gao, S; Maldonado, M